| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $15.15B | $14.22B | $14.37B |
| YoY Revenue Growth % | +6.5% | -1.0% | — |
| Gross Profit | $2.38B | $2.19B | — |
| Gross Margin % | 15.7% | 15.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $367.5M | $461.5M | $423.6M |
| Operating Margin % | 2.4% | 3.2% | 2.9% |
| Net Income (GAAP) | $118.7M | $216.0M | $178.2M |
| EBITDA (Normalized) | $487.4M | $611.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $567.4M | $109.2M | -$15.7M |
| Capital Expenditures (CapEx) | $149.9M | $187.3M | — |
| Free Cash Flow (FCF) | $417.5M | -$78.1M | -$15.7M |
| FCF Margin % | 2.8% | -0.5% | -0.1% |
| Return on Invested Capital (ROIC %) | 11.1% | 14.4% | — |
| Cash & Short-Term Equivalents | $6.3M | $44.0M | — |
| Total Debt (Short + Long Term) | $1.56B | $1.51B | — |
| Total Stockholders' Equity | $1.07B | $1.06B | — |